Cargando…

This Month in JAAD Case Reports: March 2022. Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2

Detalles Bibliográficos
Autor principal:	Sloan, Brett
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mosby 2022
Materias:	This month in JAAD Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695307/ https://www.ncbi.nlm.nih.gov/pubmed/34953959 http://dx.doi.org/10.1016/j.jaad.2021.12.031

Ejemplares similares

This Month in JAAD Case Reports: March 2021
por: Sloan, Brett
Publicado: (2021)

This Month in JAAD: May 2021
por: Elston, Dirk
Publicado: (2021)

This Month in JAAD: July 2021
por: Elston, Dirk M.
Publicado: (2021)

This month in JAAD International: March 2022: Photography, skin cancer, and the limits of teledermatology during the COVID-19 pandemic
por: Kantor, Jonathan
Publicado: (2022)

This Month in JAAD International: October 2022: Vaccine hesitancy and medical specialists
por: Kantor, Jonathan
Publicado: (2022)

This Month in JAAD International: August 2022: Cutaneous reactions to COVID-19 messenger RNA booster dose vaccination
por: Kantor, Jonathan
Publicado: (2022)

This month in JAAD International: November 2021: COVID-19 and hair loss
por: Kantor, Jonathan
Publicado: (2021)

Beyond JAAD October 2020: Articles of interest to dermatologists from the nondermatologic literature
por: Bronin, Andrew, et al.
Publicado: (2020)

Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2
por: Ryder, C. Yoonhee, et al.
Publicado: (2021)

July 2021: Lisinopril for delayed inflammatory responses to hyaluronic acid fillers after COVID-19 vaccinations
por: Sloan, Brett
Publicado: (2021)

January 2021: Skin of color images
por: Sloan, Brett
Publicado: (2021)

Reactive infectious mucocutaneous eruption in children diagnosed with COVID‐19
por: Bowe, Stephanie, et al.
Publicado: (2021)

May 2021: Heterogeneity in reported skin manifestations of COVID-19 and vaccines
por: Kantor, Jonathan
Publicado: (2021)

A response to “Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children’’
por: Sert, Ahmet
Publicado: (2021)

Reactive infectious mucocutaneous eruption following COVID-19 infection in vaccinated patients
por: Aw, Michael, et al.
Publicado: (2022)

Severe recurrence of reactive infectious mucocutaneous eruption with extensive ocular involvement in an adult due to SARS-CoV-2
por: Wu, David, et al.
Publicado: (2023)

Myriad of Mucocutaneous Manifestations in Multisystem Inflammatory Syndrome Associated with COVID-19
por: Prithvi, Ashwini, et al.
Publicado: (2023)

The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Peterson, Danielle, et al.
Publicado: (2020)

When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection
por: Damsky, William, et al.
Publicado: (2020)

Clinical and microbiological characteristics of reactive infectious mucocutaneous eruption: A case series of 5 patients
por: Vassallo, Camilla, et al.
Publicado: (2021)

Reactive infectious mucocutaneous eruption – repeat etanercept after intravenous immunoglobulin: A case report
por: Tonkin, Rochelle, et al.
Publicado: (2022)

Recurrent Mycoplasma pneumoniae–associated reactive infectious mucocutaneous eruption responsive to systemic steroids: A case series
por: Maredia, Hasina, et al.
Publicado: (2021)

Evolving mucocutaneous eruptions following chemotherapy
por: Chen, Ailynna, et al.
Publicado: (2022)

Strategies to prevent SARS-CoV-2 transmission during dermatologic head and neck surgery
por: Do, Mytrang H., et al.
Publicado: (2020)

Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
por: Speeckaert, Reinhart, et al.
Publicado: (2021)

Response to comment on “An evidence-based guide to SARS-Cov-2 vaccination of patients on immunotherapies in dermatology.”
por: Gresham, Louise M., et al.
Publicado: (2021)

Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization
por: Miola, Anna Carolina, et al.
Publicado: (2022)

Reply to early-onset effluvium secondary to COVID-19 and body hair effluvium
por: Wambier, Carlos Gustavo, et al.
Publicado: (2022)

If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19
por: Xu, Qiannan, et al.
Publicado: (2021)

Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?
por: Patrì, Angela, et al.
Publicado: (2020)

Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
por: Peterson, Danielle, et al.
Publicado: (2020)

JAAD Case Reports Article List
Publicado: (2022)

JAAD Case Reports Article List
Publicado: (2020)

JAAD Case Reports Article List
Publicado: (2020)

JAAD Case Reports Article List
Publicado: (2020)

In this month’s Bulletin
Publicado: (2014)

In this month’s Bulletin
Publicado: (2014)

In this month’s Bulletin
Publicado: (2015)

In this month’s Bulletin
Publicado: (2015)

In this month’s Bulletin
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_348726qpori9uhj0lcsid2i2us